Quick Answer
Gossamer Bio, Inc. reported Total Assets of $172.25 million for fiscal year 2025.
Gossamer Bio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $172.25M | -45.4% |
| 2024 | $315.29M | +1.1% |
| 2023 | $311.92M | +14.5% |
| 2022 | $272.45M | -20.7% |
| 2021 | $343.66M | -36.3% |
| 2020 | $539.43M | +26.4% |
| 2019 | $426.60M | +78.2% |
| 2018 | $239.42M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $208.82M | -40.5% | -13.3% |
| June 30, 2025 | $240.93M | -35.5% | -14.1% |
| March 31, 2025 | $280.59M | +8.2% | -11.0% |
| December 31, 2024 | $315.29M | +1.1% | -10.1% |
| September 30, 2024 | $350.88M | +0.8% | -6.0% |
| June 30, 2024 | $373.45M | +105.5% | +44.0% |
| March 31, 2024 | $259.36M | +17.9% | -16.8% |
| December 31, 2023 | $311.92M | +14.5% | -10.3% |
- Gossamer Bio, Inc. showed a decrease of -45.4% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Gossamer Bio, Inc.’s total assets has declined by 28.1% (from $239.42 million to $172.25 million).
- The most recent figure is from Gossamer Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: